Press release
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
Image: https://www.globalnewslines.com/uploads/2025/04/b69d5ad01ff487502aab6e668ddbad4c.jpgBOSTON, MASSACHUSETTS - April 9, 2025 - BIOXYTRAN, INC. (OTCQB: BIXT) (the "Company"), a clinical stage biotechnology company developing novel therapies targeting hypoxia and mitochondrial dysfunction, today highlighted the historical and scientific significance of fiber optic-based fluorometry in brain mitochondrial research. A landmark paper by Prof. Avraham Mayevsky of Bar-Ilan University was published in a book compiled by editor George Laliotis which covered key areas of biological science. Bioxytran believes this is a milestone achievement because the study commemorates 50 years of in vivo NADH redox state monitoring, highlighting the pivotal role of mitochondrial function in cellular health. This is a cornerstone of Bioxytran's BXT-25 drug development program.
- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases
- Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses
https://doi.org/10.1117/1.JBO.30.S2.S23902
The recent paper emphasizes the significance of real-time mitochondrial monitoring, particularly in addressing mitochondrial dysfunction and hypoxia - key contributors to diseases like stroke.
The groundbreaking work of Prof. Mayevsky, which introduced UV-transmitting optical fibers for tracking NADH fluorescence in vivo, paved the way for development of the MDX Viewer which is an FDA approved device that measures tissue metabolic score in real time.
Bioxytran is advancing BXT-25 toward Phase 1 trials for conditions where an oxygen transport carrier is needed to burrow through blood clots including ischemic stroke, heart attack, pulmonary embolism, chronic kidney disease (CKD), and Long Covid. The company is also exploring partnerships to integrate next-generation monitoring technologies for patient selection and use as a new vital sign.
"This anniversary paper mirrors our mission at Bioxytran - to translate decades of foundational science into life-saving therapies," stated David Platt, CEO of Bioxytran Inc. "BXT-25 builds on these principles by directly addressing the mitochondrial dysfunction observed in hypoxia-related diseases. Prof. Mayevsky's work validates the urgency of our clinical efforts."
About Bioxytran, Inc.
Bioxytran, Inc. is at the forefront of developing complex carbohydrate-based therapeutics to address critical unmet medical needs in its three core platform technologies. These include virology, cancer metastasis, and oxygen transport. In addition to ProLectin-M, Bioxytran is advancing programs for pulmonary fibrosis and stroke treatment. For more information, visit http://www.bioxytraninc.com
Investor Relations
Michael Sheikh
509-991-0245
mike.sheikh@bioxytraninc.com [mailto:mike.sheikh@bioxytraninc.com]
Forward-Looking Statements
This press release includes forward-looking statements as defined under federal law, including those related to the performance of technology described in this press release. These forward-looking statements are generally identified by the words "believe," "expect," "anticipate," "estimate," "intend," "plan," and similar expressions, although not all forward-looking statements contain these identifying words. Such statements are subject to significant risks, assumptions and uncertainties. Known material factors that could cause Bioxytran's actual results to differ materially from the results contemplated by such forward-looking statements are described in the forward-looking statements and risk factors in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and those risk factors set forth from time-to-time in other filings with the Securities and Exchange Commission. Bioxytran undertakes no obligation to correct or update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required under federal securities laws.
To view original press release on PR Gun [https://prgun.com], please visit https://prgun.com/press-release/153924/bioxytran-marks-50-years-of-mitochondrial-research-with-bxt25-advancements
Media Contact
Company Name: Bioxytran, Inc.
Contact Person: Michael Sheikh
Email: Send Email [http://www.universalpressrelease.com/?pr=bioxytran-marks-50-years-of-mitochondrial-research-with-bxt25-advancements]
Phone: 509-991-0245
City: Boston
State: Massachusetts
Country: United States
Website: https://www.bioxytraninc.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements here
News-ID: 3963930 • Views: …
More Releases from Getnews

Duque Arango Gallery Highlights Botero and Amaral in Latin American Art
Image: https://www.globalnewslines.com/uploads/2025/09/1759240454.jpg
Latin American Art: [https://galeriaduquearango.com/] Collecting Fernando Botero [https://galeriaduquearango.com/en/artist/fernando-botero/] and Olga de Amaral [https://galeriaduquearango.com/en/artist/olga-de-amaral/] with Duque Arango Gallery
When you think about Latin American art, two names immediately stand out: Fernando Botero and Olga de Amaral. Both are icons, both are Colombian artists, and both have left a mark so profound that their influence reaches far beyond the borders of Colombia and Latin America. If you've been considering collecting works by…

Spanish Wildlife Tourism Company Guarantees 95% Success Rate for Rare Animal Sig …
Image: https://www.globalnewslines.com/uploads/2025/09/1759240656.jpg
Pioneering company combines conservation education with unforgettable wildlife encounters, offering guaranteed sightings and premium equipment for nature enthusiasts
Wildlife Experiences Spain Revolutionizes Eco-Tourism with Expert-Guided Nature Adventures Across Spain's Most Pristine Landscapes
Madrid, Spain - Wildlife Experiences Spain [https://wildlifeexperiencespain.com/], a leading eco-tourism company specializing in authentic wildlife encounters and nature immersion experiences, announces its comprehensive range of expert-guided adventures designed to connect travelers with Spain's extraordinary biodiversity while promoting conservation awareness.
Founded…

A Journey of Transformation: Veronique Ziehaus' "12 Diamanten und ein Weg voller …
Image: https://www.globalnewslines.com/uploads/2025/09/1759238585.jpg
Would you dare to leave behind stability to walk into the unknown?
If not, then in this regard, you should read this book, "12 Diamanten und ein Weg voller Steine [https://www.amazon.com/dp/1967679304]", by Veronique Ziehaus. In this book the author has shared with her readers about a life-altering journey along the Camino de Santiago, discovering invaluable lessons of resilience, trust, and self-discovery. Now, her memoir is set to inspire readers worldwide…

Hangzhou conference highlights international human resources
Image: https://enapp.chinadaily.com.cn/images/202509/29/68da7088a31017a872251563.jpeg
Beijing, Shanghai, Guangzhou, Hangzhou, and Chengdu are the five Chinese cities most attractive to foreign talent, according to a new survey, with Suzhou, Shenzhen, Nanjing, Qingdao, and Xiamen following behind.
The findings of the latest survey were released at the 2025 Hangzhou International Human Resources Exchange and Cooperation Conference, which opened on Sunday in Hangzhou, Zhejiang province.
The survey was conducted by the Foreign Talent Research Center of the Ministry of…
More Releases for Bioxytran
Artificial Blood Market Set to Witness Significant Growth by 2025-2032 | Baxter …
The Artificial Blood Market Research Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Artificial Blood Market Growth from 2025 to 2032, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry players, helping them make informed decisions and stay ahead of the competition in…
Artificial Blood Market 2025 | Innovations, Applications & Global Growth Forecas …
Global Artificial Blood Market reached US$ 3760.00 million in 2023 and is expected to reach US$ 7194.83 million by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031.
Artificial Blood Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives,…
Artificial Blood Market to Reach US$ 7.19 Billion by 2031, Driven by Hemarina, K …
Global Artificial Blood Market reached US$ 3760.00 million in 2023 and is expected to reach US$ 7194.83 million by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031.
Artificial Blood Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the…
Artifical Blood Market Size Analysis and Regional Analysis Forecast to (2024-203 …
DataM Intelligence has published a new research report on "Artificial Blood Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/artificial-blood-market
The…
Shaping the Future: Circulating Galectin Inhibitor Market's Forward-Thinking Tre …
This Market study covers the Global and Regional "Circulating Galectin Inhibitor Market" with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The Circulating Galectin Inhibitor Market report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts. The report also…
Acute Respiratory Distress Syndrome (ARDS) Market Key Company Profile, Trends an …
Acute Respiratory Distress Syndrome (ARDS) Market Insights, Epidemiology and Market Forecast 2030 report delivers an in-depth understanding of the Acute Respiratory Distress Syndrome (ARDS), historical and forecasted epidemiology as well as the Acute Respiratory Distress Syndrome (ARDS) market trends in the United States, EU5 (Germany, France, Italy, and United Kingdom) and Japan.
The Acute Respiratory Distress Syndrome (ARDS) market report provides current treatment practices, emerging drugs, and market share of the…